Goblet Cells in SARS-CoV-2 Pathogenesis |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.11, No. 1)Publication Date: 2020-11-25
Authors : Masfique Mehedi;
Page : 102-104
Keywords : Receptor; Angiotensin; Infection; Bronchial epithelial; Corticosteroids;
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, a causative agent of coronavirus disease 2019, COVID-19) cellular tropism depends on its receptor-binding specificity. Therefore, the answer for why SARS-CoV-2 is more transmissible than SARS-CoV may find in the expression of the entry receptor angiotensin-converting enzyme II (ACE2) on host cells. SARS-CoV-2 spike protein shows ten times more affinity in binding ACE2 than does SARS-CoV [1]. For successful SARS-CoV-2 entry, spike protein priming is required by a host cell co-factor transmembrane serine protease 2 (TMPRSS2) [2]. Thus, cells with high ACE2 and TMPRSS2 expression are more susceptible to SARS-CoV-2. Previously, RNA-seq based studies suggested that both ACE2 and TMPRSS2 predominately express by the secretory cells in the respiratory system [3-5]. Recent studies suggest that mucus-secreting goblet cells are permissive to SARS-CoV-2 infection [6-8].
Other Latest Articles
- Covid-19 Pandemic and Climate Change: A Review on the Response of Countries to Both Phenomena |Biomedgrid
- Access Barriers and Health Care in Patients with Chronic Respiratory Diseases |Biomedgrid
- Influence of Food Attributes on Purchasing Behavior of Food Deseret Residents in Eastern Greensboro, NC: Multidimensional Scaling Approach |Biomedgrid
- Gastrointestinal Stromal Tumors of The First Jejunal Small Bowel: A Case Report |Biomedgrid
- Application of Nanomaterials in Brain Cancers Diagnosis and Treatment: A Mini-Review |Biomedgrid
Last modified: 2023-07-11 21:49:32